In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
- Nintedanib plus standard chemotherapy (pemetrexed/cisplatin) demonstrated a 46% reduction in the risk of disease progression in patients with inoperable malignant pleural mesothelioma (MPM) compared to placebo plus standard chemotherapy